Vanguard Investments Australia »

Palvella Therapeutics Inc Ne shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-03-31 $322k 2.6k 124.65

More positions owned by Vanguard Investments Australia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Investments Australia

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Group
Vanguard Capital Management
Federated Investors
State Street Corporation
Summit Partners Public Asset Management
Woodline Partners
Alliancebernstein
FMR
MPM Oncology Impact Management

View all funds holding Palvella Therapeutics Inc Ne